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How could we know if communication skills training needed no more evaluation? The case 
for rigour in research design 
An updated Cochrane review has confirmed the findings of previous reviews – that 
communication skills training (CST) can change oncology practitioners’ behavior, but without 
clear evidence that patients benefit[1]. The authors conclude that more research needs to be done, 
and that this research must be of better quality than the studies they reviewed. Educational 
researchers also recognize the need for stronger evaluations, as Bylund et al recently illustrated 
in a report explicitly titled a ‘robust’ evaluation[2]. But what does robust evaluation mean in this 
context? 
Most evaluations in PEC over recent years have, like Bylund et al’s, emphasized 
statistical testing of effects on outcomes, often in the context of randomized trials, thereby 
aligning CST evaluation with the ‘hierarchy of evidence’ against which the efficacy of 
interventions across medicine is now routinely judged. CST evaluation is difficult, because it 
must contend with real-world constraints that exclude elements of quality research design that 
are common in clinical research. For instance, participants cannot be blinded to being trained. 
Similarly, randomization can be impractical where a training program is embedded across an 
institution[2]. Nevertheless, the standards by which quantitative evaluations of clinical 
interventions are now routinely scrutinized[3] provide pointers to what robust CST evaluation 
could look like. When judged against these standards, evaluations of CST that have been 
influential historically now look weak, and more recent evaluations lack essential elements of 
quality[4]. Here we identify ways in which such evaluation could improve if it is to become 
sufficiently robust to command authority more generally in clinical medicine – and to help 
reviewers tell when enough research of this kind has been done. 
 
First, choose the primary outcome 
The starting point for evaluation to reach current standards is a primary hypothesis that 
specifies a primary outcome; that is, a dependent variable on which success or failure of the 
intervention can be judged. The more statistical comparisons that are performed, the greater the 
risk that significant findings reflect random processes, so clinical trials normally specify only one 
or a very few primary outcomes[3]. Other outcomes are ‘secondary’; that is, they answer 
questions other than ‘did the intervention work?’ Primary outcomes should be documented in 
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advance in a registered protocol to exclude any risk that outcomes are prioritized according to 
how they perform in data analysis. CST evaluation has not routinely distinguished between 
primary and secondary outcomes, or used pre-registered protocols. Girgis et al’s report was a 
valuable exception in distinguishing primary from secondary outcomes[5]; however, since their 
primary outcome (emotional function) did not change, the inference should arguably be that 
intervention failed, notwithstanding the response of one secondary outcome (anxiety). When 
other studies have specified hypotheses, there have typically been multiple primary outcomes. 
For instance, the ‘primary hypothesis’ of a widely cited evaluation referred to eight outcome 
measures (each analyzed in multiple ways), only half of which responded[6]. In Bylund et al’s 
report[2], evaluation was considered robust, in part, because of the range of variables measured at 
different levels, from learners’ course evaluation to their patients’ experience. Therefore, the 
primary research question entailed statistical comparisons of more than 100 outcomes, of which 
around half responded[2]. In another report, 13 out of 30 outcomes responded[7]; in another, 
seven out of 11[8]. Given that such studies routinely use the conventional significance criterion 
of p<.05, some findings probably reflect random variation. 
CST evaluators do face a challenge in choosing primary outcomes because of the breadth 
of variables relevant to learning to communicate[9]. Outcomes can encompass learners’ 
subjective experience, including satisfaction with training and confidence in communication, 
their performance of skills, and their patients’ experience. While some of these outcomes have 
obvious face validity – learner satisfaction is a prerequisite for a training program to be viable – 
others are questionable. For instance, in a recent qualitative study, self-doubt and reflection on 
their communication were central in surgical oncologists’ accounts of learning to 
communicate[10]. From that perspective, learners’ confidence would be an ambiguous outcome: 
over-confidence might prematurely halt learning from practice. 
 
Identify the theoretical framework 
The bigger problem here is the need for theory that can give specific outcomes clear 
meaning[9, 11], and for better understanding of what practitioners need[12] and patients 
value[13]. Most evaluations implicitly or explicitly prioritize performance of communication 
skills as the most important outcomes. However, without theory that is sufficiently detailed to 
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distinguish the specific role of individual skills, findings can be hard to interpret. For instance, 
what should we make of a report that ‘empathy’ increased after CST but ‘checking 
understanding’ did not[6]? Both were predicted to increase, so did CST fail? Suppose, instead, 
that ‘checking understanding’ had increased but empathy had not. Would that be just as good 
(or poor) a result? Are the different outcomes substitutable, in that it does not matter which 
one(s) increase provided some do? Or are some outcomes more important than others; for 
instance, might ‘checking understanding’ need to increase in order that patients can benefit 
from increased ‘empathy’? The challenge for researchers is to explain the underlying theory 
linking their intervention to patient benefit more precisely than they typically do[9]. Then they 
could derive a single primary outcome (or, at most, a very few). For instance, if their theory 
predicts that patients benefit from greater use of any of the measured skills, then a primary 
outcome might be the total of individual skills. If every skill is crucial, the primary outcome 
could be whether all are displayed in any consultation. 
 
Decide on a target level of change 
Having identified a primary outcome, the trialist’s next task is to decide by how much the 
intervention should change for it to be judged successful. In CST research, this could mean 
specifying, for example, what level of patient satisfaction indicates a good consultation, or what 
level of performance of specific skills is desirable. Girgis et al were, again, unusual in specifying 
a target level of improvement (in patients’ emotional function)[5]. Specifying targets requires 
attention to starting levels. In Bylund et al’s report, baseline patient satisfaction with many 
aspects of their doctors’ communication exceeded 4.5 on a 5-point scale, so might have been 
adequate from the start[2]. Pre-training counts of skills are even harder to interpret because 
communication theory lacks clear benchmarks for their performance. For the same reason, target 
outcomes cannot usually be specified. When CST trialists seek, instead, to increase skill 
performance from whatever is the starting level, they adopt the implicit theory that ‘the more the 
better’. Taken to the limit, the target consultation style would therefore be one filled with talk 
that displays the measured skills, whether or not it achieves the clinical work that communication 
skill scoring systems often exclude. Similarly, without theory about the importance of 
confidence and self-doubt in learning communication, the implicit theory is typically that total 
confidence is better than a level that might leave learners inclined to reflect and question their 
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performance. 
Accepting the need to define a target level of change allows trialists to address a related 
element of quality in design – clinical significance. That is, what extent of change in the primary 
outcome will matter in practice? Unfortunately, while CST trials report statistical significance, 
they only rarely refer to clinical significance. Some, cautiously, warn that statistically significant 
findings might not be clinically meaningful[2] or, incautiously, suggest that non-significant ones 
might be. However, embracing clinical significance will mean a more systematic approach to 
calibrating outcomes in the context of theory that goes beyond ‘more is better’. 
 
Choose the sample size 
Having chosen a primary outcome and having specified a clinically significant level of 
change, trialists can decide how many participants will be needed to be confident of a fair test of 
training. That is, they can ensure adequate power. Unfortunately, CST trials routinely neglect 
power. In this respect, also, Girgis et al’s report was an exception, in linking their intended 
sample size to the target level of change in the primary outcome[5]. Without knowing that a 
study was adequately powered, the reader cannot know what to make of failure to find an effect. 
Were there too few participants; or was the prediction flawed? It might be thought that power no 
longer matters because meta-analyses periodically combine data from single studies into large 
data-sets with enhanced power. But under-powered trials are poor ones, increasing the risk of 
reporting bias whereby trials with few or no significant effects remain unpublished. Moreover, 
even CST meta-analyses are limited in power, given the diverse measures that different trials 
use. Considerations of power were not within the remit of the recent Cochrane review[1], but 
confidence in each of its meta-analyses depends on whether sufficient participants were available 
to them. Samples for tests of different outcomes ranged from 202-844 participants. These are 
large by the standards of CST research but might not be large enough, particularly if trialists 
were to become more ambitious in targeting patient-centred outcomes such as morbidity or 
health-related behaviour rather than practitioners’ performance of the skills they were taught. 
Studies linking practitioners’ communication to reduced morbidity in primary care, or to 
smoking cessation, have sample sizes more characteristic of epidemiology than of the small- 
scale studies that predominate in research into communication in oncology[14, 15]. 
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Is more research needed, and what kind of research? 
We can now return to our starting point: the recommendation, in response to 
unconvincing evidence for the value of CST, that ‘more research needs to be done’[1]. More 
research that disregards standards of design that are now routine across clinical evaluation risks 
adding to the mountain of ‘research waste’ that squanders resources and distorts clinical science 
because of poor design, inadequate methodology and partial or biased reporting[16]. By contrast, 
if CST trialists were to address the sequence of design decisions that begin with identifying a 
primary outcome, they might ultimately be able to reach more informative conclusions than 
‘more research needs to be done’. They might even be able to tell when no more research of this 
kind needs to be done! 
Of course, evaluations that have multiple outcomes, and that are under-powered for some 
or all of these, can be valuable as exploratory or developmental studies. They can help refine 
interventions, shape complex interventions like CST, or prepare for definitive evaluation[11]. 
They can test theory, such as in Meunier et al’s study of the role of physiological arousal in 
implementing learned skills[17]. In particular, measuring outcomes across different levels of 
effect, as Bylund et al[2] and Pehrson et al[8] did, is essential if we are to understand processes 
that mediate between teaching and practice. But it seems that, often, CST evaluators have 
conflated exploratory and definitive evaluation; based on findings from designs that are 
essentially exploratory, they have claimed the authority associated with definitive evaluation to 
advocate roll-out of CST programmes as proven elements of evidence-based practice. 
Arguably, conflating exploratory and definitive evaluation belies an enduring conflation 
of moral and evidential reasoning in justifying CST[18]. That is, belief that CST is inherently 
valuable coexists with desire to show that is effective. CST educators therefore face a broader 
challenge than simply to design better evaluations based on statistical testing of effects on 
primary outcomes. They can consider to what extent their claims to the value of CST should be 
justified by evidence that it improves outcomes, or by moral claims to its status as an essential 
element of patient-centered clinical training. To the extent that educators want to claim that CST 
improves outcomes they will, indeed, need to adopt the rigorous design standards to which 
clinical trialists are held. By contrast, to the extent that they seek to justify CST on ethical 
grounds, evidence of effects on outcomes become less important; after all, the view that 
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practitioners should be taught subjects such as clinical ethics is not ‘evidence based’. However, 
this view would bring different obligations regarding evaluation of CST. In particular, educators 
would be less concerned with standardizing and promoting existing practice. Instead, rigorous 
evaluation from this perspective would mean embracing the debate, diversity and innovation that 
is more characteristic of the medical humanities[13, 19]. PEC welcomes evaluations of CST that 
are robust from whichever perspective. 
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